Patent ID: 11912710
Assignee: UPPTHERA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 9:
10. The method according to claim 9, wherein the benign tumor or the cancer is selected from acute leukemia, adrenal cancer, anal muscle cancer, Barrett's esophagus, bladder cancer, brain cancer, breast cancer, breast cyst, breast fibroadenoma, cervical cancer, chronic leukemia, colon adenoma, colon cancer, colon polyp, colorectal cancer, endocrine cancer, endometrial cancer, esophageal cancer, gastric cancer, gastrointestinal cancer, glioblastoma, head and neck cancer, hepatocellular carcinoma, intraocular melanoma, kidney cancer, liver cancer, liver tumor, lung adenocarcinoma, lymphocytic lymphoma, monoclonal gammopathy of undetermined significance (MGUS), monoclonal lymphocytosis, non-small cell lung cancer, osteosarcoma, ovarian cancer, pancreatic cancer, parathyroid cancer, peritoneal cancer, prostate cancer, rectal cancer, salivary gland cancer, skin cancer, skin melanoma, small cell lung cancer, small intestine cancer, soft tissue sarcoma, a squamous cell carcinoma, thyroid cancer, urethral cancer, uterine cancer, or vulvar cancer, or a combination thereof.